Home › Funds › SG Americas Securities, LLC › GILD

SG Americas Securities, LLC position in GILD

GILEAD SCIENCES INC · Health Care

SG Americas Securities, LLC reported holding 5,302,793 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$604.6M, representing 0.35% of its reported portfolio and ranking #44 among its reported holdings. SG Americas Securities, LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.30M sh
Reported value held$604.63M
Portfolio Weight0.35%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SG Americas Securities, LLC's GILD position evolved

SG Americas Securities, LLC first disclosed a stake in GILD in Q3 2023 at 69,390 shares (US$5.2M). The position peaked in Q2 2026 at 5,302,793 shares, worth US$604.6M. Across 12 filings, SG Americas Securities, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,302,793 shares valued at US$604.6M — an increase of 4,327,458 shares quarter over quarter.. Notable position changes include a 440% increase in Q2 2024 (shares rose 22% over the following quarter), a 1667% increase in Q3 2025 (shares rose 10% over the following quarter), a 444% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 69.39K $5.20M New
Q4 2023 102.50K $8.30M Add
Q1 2024 154.99K $11.35M Add
Q2 2024 836.65K $56.04M Add
Q3 2024 107.86K $7.33M Reduce
Q4 2024 83.02K $3.26M Reduce
Q1 2025 152.01K $11.64M Add
Q2 2025 43.62K $4.84M Reduce
Q3 2025 770.80K $67.28M Add
Q4 2025 1.81M $156.97M Add
Q1 2026 975.34K $135.10M Reduce
Q2 2026 5.30M $604.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has SG Americas Securities, LLC held GILD?

SG Americas Securities, LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SG Americas Securities, LLC's current position in GILD?

As of Q2 2026, SG Americas Securities, LLC holds 5.30M shares of GILD (GILEAD SCIENCES INC), valued at $604.63M, representing 0.35% of its reported portfolio and ranking #44.

Has SG Americas Securities, LLC been buying or selling GILD?

In the latest 13F filing (Q2 2026), SG Americas Securities, LLC increased its position in GILD. The position peaked in Q2 2026 at 5.30M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.